The burgeoning interest in cannabis-derived substances for medical and industrial applications has necessitated a comprehensive framework for research and standardization. This presentation addresses to formulate research strategies that focus on the standardization and value generation of substances derived from natural cannabis resources. Utilizing a multi-disciplinary approach that incorporates phytochemical analysis, clinical trials, and market research, we propose a set of guidelines aimed at ensuring product quality, efficacy, and safety. Our findings indicate that a standardized protocol for extraction and characterization can lead to enhanced value generation, opening avenues for pharmaceutical and industrial applications of cannabis-derived drug prodcut. Furthermore, we identify potential market segments and regulatory challenges, offering a roadmap for stakeholders in the Korea cannabis industries. The study serves as a foundational step towards the responsible utilization of cannabis resources, contributing to sustainable development and public health objectives.